Skip to main content

Artivion, Inc.

AORT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000784199

In the last 90 days, Artivion, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $1.04B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Artivion, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $2.60M in total
Insiders trading
4
Net value
−$2.60M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Artivion, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Artivion, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Green Andrew MSVP, Regulatory and Quality40,160Sep 11, 20264
Mackin James PPresident & CEO877,275Aug 20, 20268
Berry Lance AEVP, COO, CFO & Treasurer210,112Aug 17, 20264
Holloway Jean FSVP, General Counsel184,118Aug 12, 20268
Semedo Anthony B.Director6,325IndirectJun 4, 20262
Ackerman Thomas FDirector157,472May 20, 20261
Bullock JamesDirector76,223May 20, 20261
Bevevino Daniel JDirector157,637May 20, 20261
Burbank Jeffrey HDirector61,372May 20, 20261
Salveson Jon WDirector137,416May 20, 20261
Borgstrom Marna PDirector56,664May 20, 20261
Hoff Elizabeth ADirector34,765May 20, 20262
Horton AmyVP, Chief Accounting Officer139,088Mar 4, 20268
Davis John EChief Commercial Officer230,794Mar 4, 20267
Stanton Marshall S.SVP, Clinical & MD Affair60,097Mar 4, 20267
Getz Matthew AVP, Human Resources34,116Aug 19, 20240
Maney Rochelle L.VP, Quality44,518Mar 14, 20240
Tyrs FlorianVP, Global Operations21,558Feb 29, 20240
Thomson Robert CVP Research & Development13,291Feb 26, 20240
Maier Dennis BSVP, Operations34,724Jun 8, 20230
Lee David AshleyExecutive VP, COO & CFO347,217Mar 3, 20230
Barthold Franz PeterVP, Research & Development32,516Nov 10, 20220
Morgan HarveyDirector46,342IndirectAug 31, 20210
McCall Ronald DDirector121,768Aug 26, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2026 (view filing)5:28 PM ETSep 101 dayGreen Andrew MSVP, Regulatory and QualitySSale−11.5K$24.97−$286.7K−22.2%40.2K after
Sep 4, 2026 (view filing)2:15 PM ETSep 2-32 daysGreen Andrew MSVP, Regulatory and QualitySSale−8.00K$27.03−$216.3K−13.4%51.6K after2 lots
Aug 20, 2026 (view filing)2:11 PM ETAug 191 dayMackin James PPresident & CEOSSale−70.0K$28.96−$2.03M−7.4%877.3K after
Aug 17, 2026 (view filing)3:18 PM ETAug 143 daysGreen Andrew MSVP, Regulatory and QualitySSale−616$28.55−$17.6K−1.0%59.6K after
Aug 17, 2026 (view filing)3:17 PM ETAug 143 daysBerry Lance AEVP, COO, CFO & TreasurerSSale−715$28.55−$20.4K−0.3%210.1K after
Aug 12, 2026 (view filing)5:51 PM ETAug 12Same dayHolloway Jean FSVP, General CounselSSale−977$28.49−$27.8K−0.5%184.1K after
Jun 15, 2026 (view filing)Jun 114 daysGreen Andrew MSVP, Regulatory and QualitySSale−44.0K$20.70−$910.7K−42.2%60.3K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 31 dayHorton AmyVP, Chief Accounting OfficerSSale−901$37.78−$34.0K−0.6%139.1K after
Mar 4, 2026 (view filing)Mar 3-41 dayHolloway Jean FSVP, General CounselSSale−12.8K$37.93−$485.7K−6.5%185.1K after2 lots
Mar 4, 2026 (view filing)Mar 31 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−2.15K$37.78−$81.2K−3.5%60.1K after
Mar 4, 2026 (view filing)Mar 31 dayDavis John EChief Commercial OfficerSSale−4.57K$37.78−$172.8K−1.9%230.8K after
Mar 4, 2026 (view filing)Mar 31 dayBerry Lance AEVP, COO, CFO & TreasurerSSale−6.32K$37.78−$238.6K−2.9%210.8K after
Mar 4, 2026 (view filing)Mar 31 dayMackin James PPresident & CEOSSale−17.9K$37.78−$675.8K−1.9%947.3K after
Mar 3, 2026 (view filing)Mar 21 dayHorton AmyVP, Chief Accounting OfficerSSale−641$38.02−$24.4K−0.5%132.5K after
Mar 3, 2026 (view filing)Mar 21 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−1.51K$38.02−$57.5K−3.6%40.4K after
Mar 3, 2026 (view filing)Mar 21 dayMackin James PPresident & CEOSSale−14.9K$38.02−$566.9K−1.7%848.2K after
Mar 3, 2026 (view filing)Mar 21 dayHolloway Jean FSVP, General CounselSSale−2.18K$38.02−$83.0K−1.3%170.1K after
Mar 3, 2026 (view filing)Mar 21 dayBerry Lance AEVP, COO, CFO & TreasurerSSale−5.18K$38.02−$196.9K−2.9%176.3K after
Mar 3, 2026 (view filing)Mar 21 dayDavis John EChief Commercial OfficerSSale−2.78K$38.02−$105.8K−1.3%206.5K after
Feb 25, 2026 (view filing)Feb 23-242 daysHorton AmyVP, Chief Accounting OfficerSSale−2.56K$36.97−$94.7K−2.0%127.5K after2 lots
Feb 25, 2026 (view filing)Feb 23-242 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−3.68K$36.94−$136.0K−8.1%41.9K after2 lots
Feb 25, 2026 (view filing)Feb 23-242 daysHolloway Jean FSVP, General CounselSSale−4.75K$36.92−$175.3K−3.0%152.2K after2 lots
Feb 25, 2026 (view filing)Feb 23-242 daysMackin James PPresident & CEOSSale−34.9K$36.83−$1.29M−4.4%766.1K after2 lots
Feb 25, 2026 (view filing)Feb 23-242 daysBerry Lance AEVP, COO, CFO & TreasurerSSale−9.47K$36.69−$347.3K−6.2%144.0K after2 lots
Feb 25, 2026 (view filing)Feb 23-242 daysDavis John EChief Commercial OfficerSSale−5.85K$36.92−$215.9K−3.0%188.9K after2 lots
Dec 17, 2025 (view filing)Dec 152 daysDavis John EChief Commercial OfficerSSale−5.00K$45.11−$225.6K−2.5%193.8K after
Dec 9, 2025 (view filing)Dec 81 dayHorton AmyVP, Chief Accounting OfficerSSale−4.57K$44.42−$203.1K−3.4%130.1K after
Dec 4, 2025 (view filing)Dec 31 dayMackin James PPresident & CEOSSale−30.9K$45.46−$1.41M−3.7%801.0K after10b5-1
Dec 4, 2025 (view filing)Dec 31 dayHolloway Jean FSVP, General CounselSSale−7.32K$45.30−$331.4K−4.5%156.1K after2 lots
Dec 3, 2025 (view filing)Dec 21 dayMackin James PPresident & CEOSSale−30.9K$45.56−$1.41M−3.7%801.0K after10b5-1
Nov 24, 2025 (view filing)Nov 213 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−47.4K$45.04−$2.13M−51.4%44.8K after4 lots
Nov 24, 2025 (view filing)Nov 204 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−15.3K$44.18−$674.8K−25.4%44.8K after3 lots
Nov 19, 2025 (view filing)Nov 181 dayHoff Elizabeth ADirectorSSale−4.20K$45.10−$189.4K−13.4%27.2K after
Nov 18, 2025 (view filing)Nov 14-174 daysHolloway Jean FSVP, General CounselSSale−12.8K$45.09−$576.5K−7.3%163.4K after2 lots10b5-1
Nov 18, 2025 (view filing)Nov 14-174 daysDavis John EChief Commercial OfficerSSale−12.8K$44.92−$574.4K−6.0%198.8K after2 lots10b5-1
Nov 18, 2025 (view filing)Nov 171 dayHorton AmyVP, Chief Accounting OfficerSSale−6.00K$45.73−$274.4K−4.2%135.4K after
Nov 14, 2025 (view filing)Nov 131 dayHorton AmyVP, Chief Accounting OfficerSSale−3.48K$45.86−$159.7K−2.4%141.4K after
Nov 14, 2025 (view filing)Nov 131 dayDavis John EChief Commercial OfficerSSale−6.56K$45.86−$301.0K−3.2%198.8K after
Nov 14, 2025 (view filing)Nov 131 dayMackin James PPresident & CEOSSale−34.2K$45.86−$1.57M−4.1%801.0K after
Nov 14, 2025 (view filing)Nov 131 dayHolloway Jean FSVP, General CounselSSale−5.76K$45.86−$264.2K−3.4%163.4K after
Nov 14, 2025 (view filing)Nov 131 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−4.99K$45.86−$229.0K−8.1%56.6K after
Nov 12, 2025 (view filing)Nov 10-112 daysHolloway Jean FSVP, General CounselSSale−13.0K$45.82−$593.9K−7.1%169.2K after2 lots
Nov 12, 2025 (view filing)Nov 102 daysMackin James PPresident & CEOSSale−17.6K$44.62−$784.4K−2.1%835.2K after
Nov 12, 2025 (view filing)Nov 102 daysDavis John EChief Commercial OfficerSSale−3.37K$44.62−$150.5K−1.6%205.4K after
Nov 12, 2025 (view filing)Nov 102 daysHorton AmyVP, Chief Accounting OfficerSSale−1.79K$44.62−$79.8K−1.2%144.9K after
Nov 12, 2025 (view filing)Nov 102 daysStanton Marshall S.SVP, Clinical & MD AffairSSale−2.57K$44.62−$114.5K−4.0%61.6K after
Aug 28, 2025 (view filing)Aug 271 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−18.2K$44.02−$801.2K−22.1%64.2K after
Aug 26, 2025 (view filing)Aug 251 dayHolloway Jean FSVP, General CounselSSale−10.0K$44.37−$443.7K−5.5%172.1K after
Aug 19, 2025 (view filing)Aug 154 daysMackin James PPresident & CEOSSale−12.5K$42.32−$529.0K−1.4%852.8K after
Aug 14, 2025 (view filing)Aug 122 daysDavis John EChief Commercial OfficerSSale−10.8K$43.67−$471.7K−4.9%208.8K after